Background illustration for clinical trials search

Paid Clinical Trials New Braunfels

Discover 1,437 paid clinical trials in New Braunfels, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Featured

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: San Antonio TX, The Woodlands TX, Abilene TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT07059845

Phase 2, Recruiting
Featured

A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

for
Epithelial Ovarian Cancer, Fallopian Tube Cancer,
Location: San Antonio TX, Austin TX, The Woodlands TX, Houston TX,
Sponsor: AbbVie

Sex: Female

Age: 18+

Code: NCT06890338

Phase 2, Recruiting
Featured

A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A

for
Hemophilia A
Location: San Antonio TX, Aurora CO, Iowa City IA, Tampa FL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 12+

Code: NCT07416604

Phase 3, Recruiting
Featured

A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events

for
Atherosclerosis
Location: San Antonio TX, Houston TX, Dallas TX, St Louis MO,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07448038

Phase 2, Recruiting
Featured

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

for
Diabetic Macular Edema
Location: San Antonio TX, Austin TX, Abilene TX, Germantown TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT07425522

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Featured

Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

for
Neovascular Age-related Macular Degeneration
Location: San Antonio TX, Austin TX, Round Rock TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 50+

Code: NCT07007065

Phase 3, Recruiting
Featured

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: San Antonio TX, Tomball TX, Houston TX, Pasadena TX,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07351058

Phase 3, Recruiting
Featured

A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy

for
Diabetic Retinopathy
Location: San Antonio TX, Oak Forest IL, Columbus OH, Glendale CA
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07588100

Phase 1, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer

for
Ovarian Cancer
Location: San Antonio TX, Denver CO, Omaha NE, Chicago IL,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07278336

Phase 1, Recruiting
Featured

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

for
Crohn's Disease, Ulcerative Colitis
Location: San Antonio TX, Georgetown TX, Bellaire TX, Houston TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07697456

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

for
Non-Squamous Non-Small Cell Lung Cancer, c-MET
Location: Austin TX, Houston TX, Palestine TX, Lincoln NE,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07005102

Phase 2, Phase 3, Recruiting
Featured

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

for
Obesity, Overweight
Location: Austin TX, Round Rock TX, Houston TX, Bellaire TX,
Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT07752979

Phase 2, Recruiting
Featured

Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema

for
Diabetic Retinopathy
Location: Austin TX, Bellaire TX, Burleson TX, Dallas TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07592273

Phase 2, Phase 3, Recruiting
Featured

A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer

for
Metastatic Colorectal Cancer
Location: Austin TX, Webster TX, Kansas City MO, Omaha NE,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT06820463

Phase 2, Recruiting
Featured

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

for
Chronic Migraine
Location: Austin TX, Houston TX, Waxahachie TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 12 - 17

Code: NCT06810505

Phase 3, Recruiting
Featured

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

for
Episodic Migraine
Location: Austin TX, Friendswood TX, Waxahachie TX,
Sponsor: AbbVie

Sex: All

Age: 6 - 17

Code: NCT05711394

Phase 3, Recruiting
Featured

A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Austin TX, Houston TX, Dallas TX, Tyler TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT05650632

Phase 1, Recruiting
Featured

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: Austin TX, Fort Worth TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting
Featured

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

for
Colorectal Cancer
Location: Austin TX, Houston TX, Fort Worth TX, Grapevine TX,
Sponsor: AbbVie

Sex: All

Age: 18+

Code: NCT07023289

Phase 2, Recruiting
Featured

A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With Schizophrenia

for
Schizophrenia
Location: Austin TX, Richardson TX, Little Rock AR,
Sponsor: AbbVie

Sex: All

Age: 18 - 65

Code: NCT07145918

Phase 2, Recruiting